These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29582428)

  • 1. Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia.
    Bossu A; Houtman MJC; Meijborg VMF; Varkevisser R; Beekman HDM; Dunnink A; de Bakker JMT; Mollova N; Rajamani S; Belardinelli L; van der Heyden MAG; Vos MA
    Br J Pharmacol; 2018 Jun; 175(12):2470-2482. PubMed ID: 29582428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Istaroxime, a positive inotropic agent devoid of proarrhythmic properties in sensitive chronic atrioventricular block dogs.
    Bossu A; Kostense A; Beekman HDM; Houtman MJC; van der Heyden MAG; Vos MA
    Pharmacol Res; 2018 Jul; 133():132-140. PubMed ID: 29753687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LUF7244, an allosteric modulator/activator of K
    Qile M; Beekman HDM; Sprenkeler DJ; Houtman MJC; van Ham WB; Stary-Weinzinger A; Beyl S; Hering S; van den Berg DJ; de Lange ECM; Heitman LH; IJzerman AP; Vos MA; van der Heyden MAG
    Br J Pharmacol; 2019 Oct; 176(19):3871-3885. PubMed ID: 31339551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
    Antoons G; Oros A; Beekman JD; Engelen MA; Houtman MJ; Belardinelli L; Stengl M; Vos MA
    J Am Coll Cardiol; 2010 Feb; 55(8):801-9. PubMed ID: 20170820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
    Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
    J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between temporal and spatial dispersion of repolarization in the initiation and perpetuation of torsades de pointes in the chronic atrioventricular block dog.
    Smoczyńska A; Aarnink EW; Dunnink A; Bossu A; van Weperen VYH; Meijborg VMF; Beekman HDM; Coronel R; Vos MA
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H569-H576. PubMed ID: 34355987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust anti-arrhythmic efficacy of verapamil and flunarizine against dofetilide-induced TdP arrhythmias is based upon a shared and a different mode of action.
    Oros A; Houtman MJ; Neco P; Gomez AM; Rajamani S; Oosterhoff P; Attevelt NJ; Beekman JD; van der Heyden MA; Ver Donck L; Belardinelli L; Richard S; Antoons G; Vos MA;
    Br J Pharmacol; 2010 Sep; 161(1):162-75. PubMed ID: 20718748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes.
    Nalos L; Varkevisser R; Jonsson MK; Houtman MJ; Beekman JD; van der Nagel R; Thomsen MB; Duker G; Sartipy P; de Boer TP; Peschar M; Rook MB; van Veen TA; van der Heyden MA; Vos MA
    Br J Pharmacol; 2012 Jan; 165(2):467-78. PubMed ID: 21718297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model.
    Varkevisser R; van der Heyden MA; Tieland RG; Beekman JD; Vos MA
    Eur J Pharmacol; 2013 Nov; 720(1-3):49-54. PubMed ID: 24211677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point of View: Electrophysiological Endpoints Differ When Comparing the Mode of Action of Highly Successful Anti-arrhythmic Drugs in the CAVB Dog Model With TdP.
    van Weperen VYH; Bossu A; Vos MA
    J Cardiovasc Pharmacol; 2019 Dec; 74(6):499-507. PubMed ID: 31738198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of physiological late Na
    El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.
    Dunnink A; van Opstal JM; Oosterhoff P; Winckels SK; Beekman JD; van der Nagel R; Cora Verduyn S; Vos MA
    Europace; 2012 Mar; 14(3):431-6. PubMed ID: 21946817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I
    van Bavel JJA; Beekman HDM; van Weperen VYH; van der Linde HJ; van der Heyden MAG; Vos MA
    Eur J Pharmacol; 2022 Oct; 932():175218. PubMed ID: 36007604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
    Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
    Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late I
    Hwang J; Kim TY; Terentyev D; Zhong M; Kabakov AY; Bronk P; Arunachalam K; Belardinelli L; Rajamani S; Kunitomo Y; Pfeiffer Z; Lu Y; Peng X; Odening KE; Qu Z; Karma A; Koren G; Choi BR
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e006875. PubMed ID: 32628505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
    Boulaksil M; Jungschleger JG; Antoons G; Houtman MJ; de Boer TP; Wilders R; Beekman JD; Maessen JG; van der Hulst FF; van der Heyden MA; van Veen TA; van Rijen HV; de Bakker JM; Vos MA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):566-76. PubMed ID: 21622813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.